Considering that cancer prevention spans exposure to a carcinogen (primary prevention), initiation, promotion, and progression of cancer (secondary prevention), and invasion and metastasis (tertiary prevention) [71], natural inhibitors of protein kinases can be chosen according to the type of cancer and/or the type of applied care and therapy with personalization and precision. The gene discussed is WEE1; the disease is cancer.